Found 95 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
Early Access Program of Lazertinib in Republic of Korea
N/AThis early access program will be conducted to provide access to Lazertinib...
Status
Approved For Marketing
Location
Multiple Locations
Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC
PHASE2This single-arm phase II study aims to study the efficacy of a possible fir...
Location
Xinqiao Hospital of Chongqing
Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease
PHASE1This trial is testing two novel combinations (temozolomide plus osimertinib...
Location
University of Colorado Hospital
Phase 3 Clinical Study of AK112 for NSCLC Patients
PHASE3A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
N/AThe goal of this observational study is to extract the imaging features of ...
Location
Shanghai Cancer center
Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.
PHASE2This is a multi-center, open-label, phase II clinical study of MCLA-129 as ...
Location
The First Affiliated Hospital of Anhui Medical University
Acquired Resistant Mechanism of the First-generation EGFR TKIs
N/APatients with advanced non-small-cell lung cancer (NSCLC) harboring sensiti...
Location
Zhejiang Cancer Hospital
Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases
PHASE2Patients will receive AZD9291 at a dose of 80 mg once daily. Intracranial r...
Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy
PHASE2There are two different treatment modes for NSCLC patients who failed to ep...
Location
Department of Respiratory Medicne, Peking Union Medical Hospital